Isoniazid metabolism is influenced by N-acetyltransferase enzyme polymorphism.
Patients with slow acetylation exhibit reduced drug clearance, leading to higher plasma concentrations and increased drug effects.
Fast acetylators metabolize isoniazid rapidly, requiring higher doses for therapeutic efficacy.